Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Rimondini

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
The European Journal of Neuroscience|December 3, 1999
Stimulation of adenosine A1 receptors attenuates dopamine D1 receptor-mediated increase of NGFI-A, c-fos and jun-B mRNA levels in the dopamine-denervated striatum and dopamine D1 receptor-mediated turning behaviourS Ferré, R Rimondini, P Popoli, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 2000
Behavioral insensitivity to restraint stress, absent fear suppression of behavior and impaired spatial learning in transgenic rats with hippocampal neuropeptide Y overexpressionA Thorsell, M Michalkiewicz, Y Dumont, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 3, 1999
"Atypical" neuromodulatory profile of glutapyrone, a representative of a novel 'class' of amino acid-containing dipeptide-mimicking 1,4-dihydropyridine (DHP) compounds: in vitro and in vivo studiesI Misane, V Klusa, M Dambrova, et al.
Neuroscience Letters|August 15, 1994
PEC-60 increases dopamine but not GABA release in the dorsolateral neostriatum of the halothane anaesthetized rat. An in vivo microdialysis studyR Rimondini, W T O'Connor, S Ferré, et al.
Neuroscience|August 1, 1996
Evidence for a differential cholecystokinin-B and -A receptor regulation of GABA release in the rat nucleus accumbens mediated via dopaminergic and cholinergic mechanismsL Ferraro, W T O'Connor, X M Li, et al.
Parkinsonism & Related Disorders|May 2, 2001
Adenosine/dopamine interaction: implications for the treatment of Parkinson's diseaseS Ferré, P Popoli, L Giménez-Llort, et al.
Nature|January 15, 1998
Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotineM R Picciotto, M Zoli, R Rimondini, et al.
Advances in Neurology|September 14, 2001
Adenosine receptors and Parkinson's disease. Relevance of antagonistic adenosine and dopamine receptor interactions in the striatumK Fuxe, I Strömberg, P Popoli, et al.
Gut Microbes|September 15, 2023
Disruption of the microbiota-gut-brain axis is a defining characteristic of the α-Gal A (-/0) mouse model of Fabry diseaseC Delprete, R Rimondini Giorgini, E Lucarini, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
The European Journal of Neuroscience|December 3, 1999
Stimulation of adenosine A1 receptors attenuates dopamine D1 receptor-mediated increase of NGFI-A, c-fos and jun-B mRNA levels in the dopamine-denervated striatum and dopamine D1 receptor-mediated turning behaviourS Ferré, R Rimondini, P Popoli, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 1, 2000
Behavioral insensitivity to restraint stress, absent fear suppression of behavior and impaired spatial learning in transgenic rats with hippocampal neuropeptide Y overexpressionA Thorsell, M Michalkiewicz, Y Dumont, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 3, 1999
"Atypical" neuromodulatory profile of glutapyrone, a representative of a novel 'class' of amino acid-containing dipeptide-mimicking 1,4-dihydropyridine (DHP) compounds: in vitro and in vivo studiesI Misane, V Klusa, M Dambrova, et al.
Neuroscience Letters|August 15, 1994
PEC-60 increases dopamine but not GABA release in the dorsolateral neostriatum of the halothane anaesthetized rat. An in vivo microdialysis studyR Rimondini, W T O'Connor, S Ferré, et al.
Neuroscience|August 1, 1996
Evidence for a differential cholecystokinin-B and -A receptor regulation of GABA release in the rat nucleus accumbens mediated via dopaminergic and cholinergic mechanismsL Ferraro, W T O'Connor, X M Li, et al.
Parkinsonism & Related Disorders|May 2, 2001
Adenosine/dopamine interaction: implications for the treatment of Parkinson's diseaseS Ferré, P Popoli, L Giménez-Llort, et al.
Nature|January 15, 1998
Acetylcholine receptors containing the beta2 subunit are involved in the reinforcing properties of nicotineM R Picciotto, M Zoli, R Rimondini, et al.
Advances in Neurology|September 14, 2001
Adenosine receptors and Parkinson's disease. Relevance of antagonistic adenosine and dopamine receptor interactions in the striatumK Fuxe, I Strömberg, P Popoli, et al.
Gut Microbes|September 15, 2023
Disruption of the microbiota-gut-brain axis is a defining characteristic of the α-Gal A (-/0) mouse model of Fabry diseaseC Delprete, R Rimondini Giorgini, E Lucarini, et al.
Pageof 4